BellyFlush Ingredients: What Each Botanical Does

The first of three stimulant laxatives here. Its anthraquinone glycosides pass the small intestine intact, colonic bacteria cleave them, and the freed anthrones stimulate the colon wall. Evidence: a century of use and very little modern controlled testing. the FDA's 2002 final rule states that cascara sagrada, including the bark, is not generally recognized as safe and effective in over-the-counter laxative drug products, because the data asked for were never submitted. That governs drug products, not supplements, so this capsule is lawful, and no sales page mentions it. Demarque 2018 links anthranoid cell toxicity to the side effects people report.

The dried latex from the leaf, not the clear inner gel sold for skin. That distinction matters more than any other here: the gel soothes, the latex is a powerful anthraquinone purgative, and a colon formula uses the latter. Evidence: aloe is the second ingredient named in the FDA's 2002 final rule, carrying the same finding for the same reason. the NCCIH aloe vera page sets out what is and is not known and notes the safety concerns with oral latex preparations. The one controlled constipation trial we can point at, Odes 1991, tested a combination containing celandine and psyllium too, so it cannot tell you what the aloe contributed alone.

The third stimulant laxative, and the only one with a solid modern trial record. Senna acts through sennosides, the same anthraquinone route, and it is the active ingredient in several pharmacy laxatives sold today. Evidence: Morishita 2021 is a randomized, placebo-controlled trial in adults with chronic constipation, comparing senna against magnesium oxide. a Cochrane review reviews the class more broadly, and the joint AGA and ACG guideline places stimulant laxatives in the recognised treatment ladder. The gap: every one of those describes a stated dose of sennosides. This label publishes none, so a reader cannot line this capsule up against any of them.

Not one fruit but three: amalaki, bibhitaki and haritaki, usually in equal parts. It is the mildest mover here and the one with the longest record of traditional use. Evidence: Tarasiuk 2018 is the most useful modern overview, covering what is proposed for functional gastrointestinal disorders and what has actually been measured. Munshi 2011 is an open-label prospective study of a triphala-based formulation in functional constipation. Open-label means everyone knew what they were taking, which is a real limitation in a symptom-reported condition where placebo response runs high.

A carminative, traditionally used to ease trapped wind and cramping. On a panel built around three purgatives, the carminatives make the experience tolerable rather than adding to the effect. Evidence: Portincasa 2016 is a randomized trial of curcumin and fennel essential oil in irritable bowel syndrome that reported improved symptoms and quality of life. It used an essential oil at a stated dose inside a two-ingredient combination. This label names fennel seed with no amount and no extraction detail, so the read-across is weak. Hawrelak 2020 is the wider systematic review and the better place to start.

A swelling volcanic-ash clay with a strong negative surface charge, which is why it binds positively charged molecules and why it turns up in cleanse formulas. Evidence: there is no controlled human trial of oral bentonite for bloating or colon health that we are willing to cite as support. What we can point at is the safety literature: Al-Rmalli 2010 measured arsenic and other toxic elements in clay eaten traditionally, which is why the source matters. This desk has seen no heavy-metal certificate for this one. Practical point: a binder can bind medication. Keep this capsule at least two hours away from anything prescribed.

Mucilaginous. In water it forms a slippery gel, and that gel is the whole traditional rationale: it coats and soothes a stimulated bowel. Evidence: the mucilage itself is well characterised, and Rownaghi 2024 measured the extracted polysaccharide in detail. What does not exist, as far as we can find, is a randomized controlled trial of oral marshmallow root for any digestive endpoint in adults. We say that plainly rather than citing a laboratory paper as if it were a clinical result. the NIH Office of Dietary Supplements is a short primer on reading that difference.

The ingredient here that most deserves a warning, and the one buyers underestimate because it is also a sweet. Evidence for: Raveendra 2012 is a randomized, double-blind, placebo-controlled trial of a standardised licorice extract in functional dyspepsia that reported symptom relief, and the NCCIH licorice root page summarises the plant and its cautions. Evidence against taking it casually: Penninkilampi 2017 pooled the studies on consistent licorice intake and found an association with raised blood pressure and lowered potassium. Glycyrrhizin lets cortisol act on the kidney's mineralocorticoid receptor, imitating excess aldosterone, and the three laxatives push potassium the same way. The label does not say whether the extract is deglycyrrhizinated.

The second demulcent, and traditionally the gentler one. Slippery elm inner bark forms the same kind of mucilage as marshmallow root. Evidence: Hawrelak 2010 is a pilot study of two natural medicine formulations in irritable bowel syndrome, one of which contained slippery elm. It is small, it is a pilot, and the herb sat inside a combination. That is the honest state of the evidence, and Hawrelak 2020 places it in the wider picture. Nobody has run a properly powered trial of slippery elm alone for bloating.

On this panel as a traditional circulatory and digestive stimulant. Its active compound is capsaicin, the molecule responsible for heat. Evidence: capsaicin unquestionably does something in the gut. Fuhrer 2011 gave an oral capsaicin load to people with functional dyspepsia in a placebo-controlled trial and measured the response. The direction of that response is the part most product pages leave out: in sensitive people capsaicin provokes symptoms rather than settling them. If chilli already gives you heartburn, this is an ingredient to notice on the label rather than to welcome.

The only ingredient here not aimed at the bowel. Milk thistle seed provides silymarin, and it supports the word detox on the front of the bottle. Evidence: silymarin is genuinely well studied by botanical standards. Li 2024 is a systematic review and meta-analysis in fatty liver disease, and the NCCIH milk thistle page gives the balanced read. Neither licenses loose use of the word detox: those trials studied people with a diagnosed liver condition, at standardised doses, over months. Note on the picture: the vendor art illustrates this with the milk thistle flower. The label names the seed, which is where silymarin concentrates.